Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives.
Sievers J, Voget R, Lu F, Garchitorena KM, Ng YLD, Chau CH, Steinebach C, Figg WD, Krönke J, Gütschow M. Sievers J, et al. Among authors: figg wd. Bioorg Med Chem Lett. 2024 Sep 15;110:129858. doi: 10.1016/j.bmcl.2024.129858. Epub 2024 Jun 23. Bioorg Med Chem Lett. 2024. PMID: 38917956 Free article.
New Discorhabdin D Analogues from Latrunculia spp. Sponges.
Orfanoudaki M, Dalilian M, Du L, Chau CH, Figg WD, O'Keefe BR, Grkovic T. Orfanoudaki M, et al. Among authors: figg wd. J Nat Prod. 2024 Nov 22;87(11):2640-2648. doi: 10.1021/acs.jnatprod.4c01036. Epub 2024 Oct 25. J Nat Prod. 2024. PMID: 39453729
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Gandhy SU, Karzai FH, Bilusic M, McMahon S, Cordes LM, Marte J, Weisman AJ, Perk TG, Lindenberg L, Mena E, Turkbey B, Arlen PM, Dahut WL, Figg WD, Choyke P, Gulley JL, Madan RA. Gandhy SU, et al. Among authors: figg wd. Eur Urol Oncol. 2024 Aug;7(4):735-741. doi: 10.1016/j.euo.2023.09.010. Epub 2023 Oct 17. Eur Urol Oncol. 2024. PMID: 37858437 Clinical Trial.
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. Among authors: figg wd. J Exp Clin Cancer Res. 2023 Apr 26;42(1):102. doi: 10.1186/s13046-023-02668-3. J Exp Clin Cancer Res. 2023. PMID: 37101182 Free PMC article. No abstract available.
Relugolix in Clinical Practice: The Best Route for All?
Cordes LM, Karzai F, Figg WD, Madan RA. Cordes LM, et al. Among authors: figg wd. Oncologist. 2023 Aug 3;28(8):647-650. doi: 10.1093/oncolo/oyad099. Oncologist. 2023. PMID: 37162497 Free PMC article.
793 results